

The Top 100 Drugs - Elsevier E-Book on VitalSource (Retail Access Card), 3rd Edition
Elsevier eBook on VitalSource - Access Card

-
- Compact and easy to follow – can be carried around on the wards
- Logically ordered – offers multiple ways to find the drug you are looking for
- A Clinical Tip for each drug, drawn from the authors’ experience
- 100 self-assessment questions to encourage integration and revision of knowledge and understanding
-
- Fully updated to include the most commonly prescribed drugs today, based on original research led by the authors of over 1 billion community prescriptions and approximately 1 million hospital prescriptions
- All drug monographs extensively reviewed and updated
- Dedicated section emergency drugs
- Updated self-assessment material, now including calculation and prescription-writing questions, in addition to single-best-answer questions
-
List of abbreviations
Introduction
The top 100 drugs listed by system
The top 100 drugs listed by indication
The top 100 drugs (alphabetical listing)
5a-reductase inhibitors
a-blockers
Acetylcholinesterase inhibitors
Acetylcysteine (N-acetylcysteine)
Activated charcoal
Adenosine
Adrenaline (epinephrine)
Aldosterone antagonists
Alginates and antacids
Allopurinol
Aminoglycosides
Aminosalicylates
Amiodarone
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin receptor blockers
Antidepressants, selective serotonin reuptake inhibitors
Antidepressants, tricyclics and related drugs
Antidepressants, venlafaxine and mirtazapine
Antiemetics, dopamine D2-receptor antagonists
Antiemetics, histamine H1-receptor antagonists
Antiemetics, serotonin 5-HT3-receptor antagonists
Antifungal drugs
Antihistamines (H1-receptor antagonists)
Antimotility drugs
Antimuscarinics, bronchodilators
Antimuscarinics, cardiovascular and gastrointestinal uses
Antimuscarinics, genitourinary uses
Antipsychotics, first-generation (typical)
Antipsychotics, second-generation (atypical)
Antiviral drugs
Antiplatelet drugs, ADP-receptor antagonists
Antiplatelet drugs, aspirin
Azathioprine
ß-blockers
ß2-agonists
Benzodiazepines
Bisphosphonates
Calcium and vitamin D
Calcium channel blockers
Carbamazepine
Cephalosporins and carbapenems
Chloramphenicol
Corticosteroids (glucocorticoids), inhaled
Corticosteroids (glucocorticoids), systemic
Corticosteroids (glucocorticoids), topical
Digoxin
Dipeptidylpeptidase-4 inhibitors
Direct oral anticoagulants
Diuretics, loop
Diuretics, thiazide and thiazide-like
Dopaminergic drugs for Parkinson’s disease
Emollients
Fibrinolytic drugs
Gabapentin and pregabalin
H2-receptor antagonists
Heparins and fondaparinux
Insulin
Iron
Lamotrigine
Laxatives, osmotic
Laxatives, stimulant
Leukotriene receptor antagonists
Levetiracetam
Lidocaine
Macrolides
Metformin
Methotrexate
Metronidazole
Naloxone
Nicotine replacement and related drugs
Nitrates
Nitrofurantoin
Non-steroidal antiinflammatory drugs
Ocular lubricants (artificial tears)
Oestrogens and progestogens
Opioids, strong
Opioids, weak/moderate
Oxygen
Paracetamol
Penicillins
Penicillins, antipseudomonal
Penicillins, broad-spectrum
Penicillins, penicillinase-resistant
Phosphodiesterase (type 5) inhibitors
Prostaglandin analogue eye drops
Proton pump inhibitors
Quinine
Quinolones
Serotonin 5-HT1-receptor agonists
Sex hormone antagonists for breast cancer
Statins
Sulphonylureas
Tetracyclines
Thyroid hormones
Trimethoprim
Valproate (valproic acid)
Vancomycin
Vitamins
Warfarin
Z-drugs
Fluids
Colloids (plasma substitutes)
Compound sodium lactate (Hartmann’s solution)
Glucose (dextrose)
Potassium chloride
Sodium chloride
Self-assessment and knowledge integration
100 single best-answer questions
Answers and explanations
Index
-
Andrew Hitchings, BSc, MBBS, PhD, FRCP, FFICM, FHEA, FBPhS, Reader in Clinical Pharmacology, St George’s, University of London, Honorary Consultant in Neurointensive Care, St George’s University Hospitals NHS Foundation Trust, London, Dagan Lonsdale, BSc(Hons) MBBS PhD MRCP FHEA FFICM, Honorary Senior Lecturer, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Intensive Care Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK, Daniel Burrage, BSc(Hons) MBBS MSc (Med Ed) MRCP FHEA, NIHR Doctoral Research Fellow, St George’s, University of London; Specialty Registrar in Clinical Pharmacology, General Medicine and Stroke Medicine, St George’s University Hospitals NHS Foundation Trust, London, UK and Emma Baker, MBChB PhD FRCP FBPhS, Professor of Clinical Pharmacology, St George’s University of London; Honorary Consultant Physician, St George’s University Hospitals NHS Foundation Trust, London, UK.